Closed tender · Ukraine · Public tender
ДК 021:2015 - 33600000-6 Фармацевтична продукція: Інсулін гларгін, розчин для ін'єкцій, 100 Од/мл, по 3 мл (Insulin glargine), Інсулін людини (Середньої тривалості дії), суспензія для ін’єкцій, 100 Од/мл, картридж, по 3 мл (Insulin (human))
In EnglishDK 021:2015 - 33600000-6 Pharmaceutical products: Insulin glargine, solution for injection, 100 IU/ml, 3 ml each (Insulin glargine), Human insulin (intermediate-acting), suspension for injection, 100 IU/ml, cartridge, 3 ml each (Insulin (human))
Комунальне підприємство "Полтавська обласна клінічна лікарня ім.М.В.Скліфосовського Полтавської обласної ради" in Ukraine invited bids for “DK 021:2015 - 33600000-6 Pharmaceutical products: Insulin glargine, solution for injection, 100 IU/ml, 3 ml each (Insulin glargine), Human insulin…”. Bids closed on 12 October 2026, 08:00 EEST; the estimated value is UAH 19,468.
The tender in brief
Supply of insulin glargine and human insulin to a Poltava hospital, for licensed pharmaceutical suppliers
The Poltava Regional Clinical Hospital named after M.V. Sklifosovsky is buying insulin glargine solution for injection (100 IU/ml, 3 ml) and human insulin (intermediate-acting) suspension for injection (100 IU/ml, 3 ml cartridge). Quantities are 50 units of insulin glargine and 15 units of human insulin, delivered to Poltava. The expected value is 19,468 UAH and the procurement uses a price quotation method.
Who can win it
- The bidder, its ultimate beneficial owner, member or shareholder must not be subject to sanctions banning public procurement
- The bidder must not be a legal entity registered in Russia, Belarus or Iran, nor have owners from those countries with 10% or more share
- The country of origin of the goods must not be Russia, Belarus or Iran
Key facts
- Estimated value
- UAH 19,468
Public data: Prozorro. · Sources & licences